Skip to content
Open access

Clinical Significance and Changes in Levels of Serum BDNF, mBDNF, AQP4, proBDNF, and GSK3β in Individuals Diagnosed With Bipolar Disorder: A Cross‐Sectional Study

Aug 2026 · Health Science Reports · Vol 9 · 0 citations · 42 references
Medicine

Abstract

Bipolar disorder (BD) is a severe mood disorder with unclear pathogenesis and limited diagnostic biomarkers. This study aimed to evaluate serum levels of BDNF, mBDNF, AQP4, proBDNF, and GSK3β between BD patients and healthy controls, and to preliminarily explore their potential clinical significance.

Read PDF

Similar papers

Open access Jul 2026

Association of GBA1 status and sex with depression severity and progression in Parkinson's disease.

GBA1 variants increase neuropsychiatric vulnerability in Parkinson's disease (PD). In a multicenter cohort of 234 PD patients (78 GBA-PD, 156 nonGBA-PD), we investigated how GBA1 genotype and sex relate to depression. REM sleep behavior disorder was associated with depression in GBA-PD, while sex, cognition, and motor...

P. Mitrotti, M. Avenali, C. Artusi et al. · 0 citations
Jul 2026

Circulating levels of BDNF, 5-HT and KYN pathway metabolites are associated with psychotic symptoms in adults with ASD

Abstract Background and aims Recent translational and clinical research emphasise the concept of interacting neurochemical disruptions as a ground for the development of psychosis. At the same time, literature highlighted neurostructural and functional alterations in ASD. However, evidence linking biochemical markers t...

C. Bonelli, L. Palego, B. Nardi et al. · 0 citations
Open access Jul 2026

A novel perspective on biomarkers of neurodegeneration and neuroinflammation in first episode psychosis: a cross-sectional study

The biological distinction between first-episode psychosis (FEP) and chronic schizophrenia remains unclear. This study investigated a panel of non-canonical serum biomarkers related to neurodegeneration, neuroinflammation, and neurotrophic signaling across these clinical stages. In a cross-sectional design, serum conce...

V. Zakurazhnaya, Y. Zorkina, O. Abramova et al. · 0 citations
Open access Sep 2026

Serum VIP and IL‐1β Levels Are Associated With Anxiety and Depression in Patients With Parkinson's Disease: A Cross‐Sectional Study

This study evaluated whether circulating concentrations of vasoactive intestinal peptide, interleukin‐1β (IL‐1β), and tumor necrosis factor‐alpha (TNF‐α) differed according to the presence of anxiety and depressive symptoms among individuals with PD.

Liang-Yu Li, Xiao-Yang Jia, Ying-Chang Shi et al. · 0 citations
Open access Aug 2026

Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment‐Naïve Relapsing‐Remitting Multiple Sclerosis

To investigate whether neuromuscular fatigue and anxiety are associated with a peripheral biological signature involving inflammation, oxidative stress, mitochondrial homeostasis, neurotrophic support, and neuronal/glial injury markers in treatment‐naïve patients with relapsing‐remitting multiple sclerosis (RRMS).

Amanda V. Steckert, Keli Dias Feltrin, Luiz Fernando Silva Rodrigues et al. · 0 citations
Jul 2026

Relationship between BDNF rs6265 (VAL66MET) polymorphism and serum BDNF LEVELS in anxiety disorders

It is demonstrated that decreased serum BDNF levels are associated with the presence and symptom severity of anxiety disorders, and the Val66Met polymorphism does not appear to be a primary determinant of serum BDNF levels in this population, suggesting that other genetic or environmental factors may be involved.

Dicle Yilmaz Uyanik, Merve Şahin Can, O. Baykan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.